75 related articles for article (PubMed ID: 32470352)
21. Celastrol activates mitochondrial autophagy through Nur77-TRAF2-p62/SQSTM1 pathway in the treatment of experimental colitis.
Chen D; Ye L; Liu Y; Yu J; Ni S; Chen Y; Zhong J
Minerva Pediatr (Torino); 2023 Oct; 75(5):760-762. PubMed ID: 37021620
[No Abstract] [Full Text] [Related]
22. Pharmacological Properties of Shionone: Potential Anti-Inflammatory Phytochemical against Different Diseases.
Jaiswal V; Lee HJ
Molecules; 2023 Dec; 29(1):. PubMed ID: 38202771
[TBL] [Abstract][Full Text] [Related]
23. Corrigendum: Unveiling the therapeutic potential of exogenous β-hydroxybutyrate for chronic colitis in rats: novel insights on autophagy, apoptosis, and pyroptosis.
Abdelhady R; Saber S; Abdel-Reheim MA; Mohammad S Alamri M; Alfaifi J; Adam MIE; Saleh LA; Farag AI; Elmorsy EA; El-Wakeel HS; Doghish AS; Shaker ME; Hazem SH; Ramadan HA; Hamad RS; Mohammed OA
Front Pharmacol; 2024; 15():1382529. PubMed ID: 38545556
[TBL] [Abstract][Full Text] [Related]
24. Novel complementary coloprotective effects of metformin and MCC950 by modulating HSP90/NLRP3 interaction and inducing autophagy in rats.
Saber S; El-Kader EMA
Inflammopharmacology; 2021 Feb; 29(1):237-251. PubMed ID: 32594364
[TBL] [Abstract][Full Text] [Related]
25. Epithelial-derived gasdermin D mediates nonlytic IL-1β release during experimental colitis.
Bulek K; Zhao J; Liao Y; Rana N; Corridoni D; Antanaviciute A; Chen X; Wang H; Qian W; Miller-Little WA; Swaidani S; Tang F; Willard BB; McCrae K; Kang Z; Dubyak GR; Cominelli F; Simmons A; Pizarro TT; Li X
J Clin Invest; 2020 Aug; 130(8):4218-4234. PubMed ID: 32597834
[TBL] [Abstract][Full Text] [Related]
26. Ferroptosis inducer erastin sensitizes NSCLC cells to celastrol through activation of the ROS-mitochondrial fission-mitophagy axis.
Liu M; Fan Y; Li D; Han B; Meng Y; Chen F; Liu T; Song Z; Han Y; Huang L; Chang Y; Cao P; Nakai A; Tan K
Mol Oncol; 2021 Aug; 15(8):2084-2105. PubMed ID: 33675143
[TBL] [Abstract][Full Text] [Related]
27. The role of the microbiome and the NLRP3 inflammasome in the gut and lung.
Donovan C; Liu G; Shen S; Marshall JE; Kim RY; Alemao CA; Budden KF; Choi JP; Kohonen-Corish M; El-Omar EM; Yang IA; Hansbro PM
J Leukoc Biol; 2020 Sep; 108(3):925-935. PubMed ID: 33405294
[TBL] [Abstract][Full Text] [Related]
28. Celastrol inhibits intestinal lipid absorption by reprofiling the gut microbiota to attenuate high-fat diet-induced obesity.
Hua H; Zhang Y; Zhao F; Chen K; Wu T; Liu Q; Huang S; Zhang A; Jia Z
iScience; 2021 Feb; 24(2):102077. PubMed ID: 33598642
[TBL] [Abstract][Full Text] [Related]
29. Celastrol induces lipophagy via the LXRα/ABCA1 pathway in clear cell renal cell carcinoma.
Zhang CJ; Zhu N; Long J; Wu HT; Wang YX; Liu BY; Liao DF; Qin L
Acta Pharmacol Sin; 2021 Sep; 42(9):1472-1485. PubMed ID: 33303989
[TBL] [Abstract][Full Text] [Related]
30. Celastrol Dilates and Counteracts Ethanol-Induced Constriction of Cerebral Arteries.
North K; Slayden A; Mysiewicz S; Bukiya A; Dopico A
J Pharmacol Exp Ther; 2020 Nov; 375(2):247-257. PubMed ID: 32862144
[TBL] [Abstract][Full Text] [Related]
31. Potential mechanisms of action of celastrol against rheumatoid arthritis: Transcriptomic and proteomic analysis.
Xinqiang S; Erqin D; Yu Z; Hongtao D; Lei W; Ningning Y
PLoS One; 2020; 15(7):e0233814. PubMed ID: 32726313
[TBL] [Abstract][Full Text] [Related]
32. Kuijieling decoction suppresses NLRP3-Mediated pyroptosis to alleviate inflammation and experimental colitis in vivo and in vitro.
Jie F; Xiao S; Qiao Y; You Y; Feng Y; Long Y; Li S; Wu Y; Li Y; Du Q
J Ethnopharmacol; 2021 Jan; 264():113243. PubMed ID: 32781258
[TBL] [Abstract][Full Text] [Related]
33. Roseburia intestinalis‑derived flagellin ameliorates colitis by targeting miR‑223‑3p‑mediated activation of NLRP3 inflammasome and pyroptosis.
Wu X; Pan S; Luo W; Shen Z; Meng X; Xiao M; Tan B; Nie K; Tong T; Wang X
Mol Med Rep; 2020 Oct; 22(4):2695-2704. PubMed ID: 32700754
[TBL] [Abstract][Full Text] [Related]
34. Dapagliflozin, an SGLT2 inhibitor, ameliorates acetic acid-induced colitis in rats by targeting NFκB/AMPK/NLRP3 axis.
El-Rous MA; Saber S; Raafat EM; Ahmed AAE
Inflammopharmacology; 2021 Aug; 29(4):1169-1185. PubMed ID: 34002329
[TBL] [Abstract][Full Text] [Related]
35. GPA peptide inhibits NLRP3 inflammasome activation to ameliorate colitis through AMPK pathway.
Deng Z; Ni J; Wu X; Wei H; Peng J
Aging (Albany NY); 2020 Sep; 12(18):18522-18544. PubMed ID: 32950971
[TBL] [Abstract][Full Text] [Related]
36. Unveiling the therapeutic potential of exogenous β-hydroxybutyrate for chronic colitis in rats: novel insights on autophagy, apoptosis, and pyroptosis.
Abdelhady R; Saber S; Ahmed Abdel-Reheim M; Mohammad S Alamri M; Alfaifi J; I E Adam M; A Saleh L; I Farag A; A Elmorsy E; S El-Wakeel H; S Doghish A; E Shaker M; H Hazem S; A Ramadan H; S Hamad R; A Mohammed O
Front Pharmacol; 2023; 14():1239025. PubMed ID: 37841914
[TBL] [Abstract][Full Text] [Related]
37. NOD-like receptors mediate homeostatic intestinal epithelial barrier function: promising therapeutic targets for inflammatory bowel disease.
Zhou F; Zhang GD; Tan Y; Hu SA; Tang Q; Pei G
Therap Adv Gastroenterol; 2023; 16():17562848231176889. PubMed ID: 37701792
[TBL] [Abstract][Full Text] [Related]
38. Alvespimycin Exhibits Potential Anti-TGF-β Signaling in the Setting of a Proteasome Activator in Rats with Bleomycin-Induced Pulmonary Fibrosis: A Promising Novel Approach.
Mohammed OA; Abdel-Reheim MA; Saleh LA; Alamri MMS; Alfaifi J; Adam MIE; Farrag AA; AlQahtani AAJ; BinAfif WF; Hashish AA; Abdel-Ghany S; Elmorsy EA; El-Wakeel HS; Doghish AS; Hamad RS; Saber S
Pharmaceuticals (Basel); 2023 Aug; 16(8):. PubMed ID: 37631038
[TBL] [Abstract][Full Text] [Related]
39. Autophagy in the pharmacological activities of celastrol (Review).
Zhang C; Wang W; Du C; Li H; Zhou K; Luan Z; Chang Y; Liu S; Wei Y
Exp Ther Med; 2023 Jun; 25(6):268. PubMed ID: 37206564
[TBL] [Abstract][Full Text] [Related]
40. Pomegranate peel extract protects against the development of diabetic cardiomyopathy in rats by inhibiting pyroptosis and downregulating LncRNA-MALAT1.
Abo-Saif MA; Ragab AE; Ibrahim AO; Abdelzaher OF; Mehanyd ABM; Saber-Ayad M; El-Feky OA
Front Pharmacol; 2023; 14():1166653. PubMed ID: 37056985
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
